Cardiovascular disease (CVD) is a global health concern, causing significant morbidity and
mortality. Both lifestyle and genetics influence the development of CVD. It is often diagnosed …

Coronavirus disease-19 (COVID-19) emerged late December 2019 in the city of Wuhan,
China and has since spread rapidly all over the world causing a global pandemic. While the …

Purpose of review: Although the respiratory system is the main target of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), it is evident from recent data that other …

The diagnosis and risk stratification of coronavirus disease 2019 (COVID-19) is primarily
based on discretionary use of laboratory resources. Several lines of evidence now attest that …

In early December 2019, the coronavirus disease (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) first emerged in Wuhan, China. As of …

The coronavirus disease 2019 (COVID-19) pandemic has become a global threat. Increases
in cardiac biomarkers are common and are associated with adverse outcomes in patients …

BACKGROUND Cardiovascular complications have been increasingly recognized in the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) associated coronavirus …

Background and aims Cardiac biomarkers like cardiac troponins and natriuretic peptides are
elevated in a substantial proportion of patients with coronavirus disease 2019 (COVID-19) …

Summary Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is erupting and
spreading globally. Cardiovascular complications secondary to the infection have caught …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic continues to
be a global challenge due to resulting morbidity and mortality. Cardiovascular (CV) …